Millennium Management LLC acquired a new position in shares of ECARX Holdings Inc. (NASDAQ:ECX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 98,280 shares of the company’s stock, valued at approximately $207,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Virtu Financial LLC purchased a new position in shares of ECARX during the fourth quarter valued at approximately $319,000. Renaissance Technologies LLC purchased a new stake in ECARX in the 4th quarter valued at $630,000. Barclays PLC bought a new position in ECARX during the 4th quarter valued at $348,000. XTX Topco Ltd bought a new position in ECARX during the 4th quarter valued at $52,000. Finally, Marshall Wace LLP purchased a new position in ECARX during the 4th quarter worth $245,000.
ECARX Price Performance
Shares of ECX stock opened at $1.59 on Friday. The firm has a 50-day moving average of $1.36 and a 200-day moving average of $1.79. The company has a market cap of $589.46 million, a P/E ratio of -3.18 and a beta of 0.56. ECARX Holdings Inc. has a one year low of $0.76 and a one year high of $3.25.
ECARX Profile
ECARX Holdings Inc develops a full stack automotive computing platform to shape the interaction between people and cars by rapidly advancing the technology by smart mobility worldwide. It offers system on chips, central computing platforms, operating systems, and software. Its core products include infotainment head units, digital cockpits, vehicle chip-set solutions, core operating system, and integrated software stack.
Further Reading
- Five stocks we like better than ECARX
- How to Invest in the FAANG Stocks
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- The Significance of Brokerage Rankings in Stock Selection
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for ECARX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ECARX and related companies with MarketBeat.com's FREE daily email newsletter.